Editas shares boosted as patent office rules in favor of Broad’s CRISPR patents

Editas shares boosted as patent office rules in favor of Broad’s CRISPR patents
Editas shares boosted as patent office rules in favor of Broad’s CRISPR patents

The U.S. Patent and Trademark Office has ruled in favor of the Broad Institute of MIT and Harvard in a dispute over the patents around CRISPR gene editing technology. | The U.S. Patent and Trademark Office has ruled in favor of the Broad Institute in a dispute over the patents around CRISPR gene editing technology, sending Editas’ shares up.